Cyclin kinase inhibitor p21: a mediator of immune tolerance: direct and indirect evidence
Ashwani Khanna
Abstract
Open-access reader
Ashwani Khanna
Abstract
Open-access reader
Abstract *Background:* Uncontrolled proliferation of T-cells is considered a barrier to the induction of transplantation tolerance by T regulatory cells. Therefore, cyclin kinase inhibitor p21, one of the most potent inhibitors of cell proliferation, may exert an important role in the induction/generation of T regulatory cells.*Methods:* CD4^+^CD25^+^ and CD4^+^CD25^-^ cells were isolated from normal healthy blood donors (n=6), p21^-/-^ mice (n=9) and wild type mice (n=9). Proliferation with and without cyclosporine was quantified by ^3^H-thymidine uptake assay (expressed as counts per minute) and FoxP3 mRNA was studied by real-time quantitative RT-PCR. *Results:* The difference in proliferation (p<0.003) among CD4^+^CD25^+^ (15236 ± 1190) and CD4^+^CD25^-^ (50317 ± 974) T cells were proportionately similar to the difference in proliferation (p<0.001) of lymphocytes from wild type (28206 ± 2812) and p21^-/-^ mice (49624 ± 2164), proliferation of CD4^+^CD25^-^ and p21 deficient cells was resistant to cyclosporine. The number of T regulatory cells in p21^-/-^ mice were significantly (p<0.002) lower (2.6 ± 0.8%) than wild type mice (14.5 ± 1.6%,) and similar to CD4^+^CD25^-^ T cells, CD4^+^25^+^ T cells from p21^-/-^ mice lacked FoxP3 gene expression. T lymphocytes from wild type inhibited the proliferation of T lymphocytes from p21^-/-^ mice similar to the effect of CD4^+^CD25^+^ T cells on the proliferation of CD4^+^CD25^-^ cells. *Conclusions:* Presence of the p21 creates a milieu favorable for immune tolerance and consistent with antiproliferative and immunosuppressive effect of CD4^+^CD25^+^ T-regulatory cells. These findings support the notion that p21 could be used clinically in controlling allo-immune activation to achieve prolongation of graft survival.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract *Background:* Uncontrolled proliferation of T-cells is considered a barrier to the induction of transplantation tolerance by T regulatory cells. Therefore, cyclin kinase inhibitor p21, one of the most potent inhibitors of cell proliferation, may exert an important role in the induction/generation of T regulatory cells.*Methods:* CD4^+^CD25^+^ and CD4^+^CD25^-^ cells were isolated from normal healthy blood donors (n=6), p21^-/-^ mice (n=9) and wild type mice (n=9). Proliferation with and without cyclosporine was quantified by ^3^H-thymidine uptake assay (expressed as counts per minute) and FoxP3 mRNA was studied by real-time quantitative RT-PCR. *Results:* The difference in proliferation (p<0.003) among CD4^+^CD25^+^ (15236 ± 1190) and CD4^+^CD25^-^ (50317 ± 974) T cells were proportionately similar to the difference in proliferation (p<0.001) of lymphocytes from wild type (28206 ± 2812) and p21^-/-^ mice (49624 ± 2164), proliferation of CD4^+^CD25^-^ and p21 deficient cells was resistant to cyclosporine. The number of T regulatory cells in p21^-/-^ mice were significantly (p<0.002) lower (2.6 ± 0.8%) than wild type mice (14.5 ± 1.6%,) and similar to CD4^+^CD25^-^ T cells, CD4^+^25^+^ T cells from p21^-/-^ mice lacked FoxP3 gene expression. T lymphocytes from wild type inhibited the proliferation of T lymphocytes from p21^-/-^ mice similar to the effect of CD4^+^CD25^+^ T cells on the proliferation of CD4^+^CD25^-^ cells. *Conclusions:* Presence of the p21 creates a milieu favorable for immune tolerance and consistent with antiproliferative and immunosuppressive effect of CD4^+^CD25^+^ T-regulatory cells. These findings support the notion that p21 could be used clinically in controlling allo-immune activation to achieve prolongation of graft survival.
Key concepts: IL-2 receptor, FOXP3, Molecular biology, Cell growth, Immune system, Biology, Chemistry, T cell